G-BA assessments of new indications
The AMNOG law dictates that every pharmaceutical product with a new chemical entity which received its marketing authorization on or after 1
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
The AMNOG law dictates that every pharmaceutical product with a new chemical entity which received its marketing authorization on or after 1
The G-BA has recently published its annual report from last year, 2020. Key statistics on the early benefit assessments The number of
Hospitals can treat patients with novel methods as soon as they become available. The treatment is reimbursed by SHI funds within the
It’s been a long time in the making, but now the G-BA finally accepted a compromise on joint HTAs conducted at the
Ever wondered if patients influence the G-BA decision-making?